Abstract
BackgroundTofacinitib is an oral Janus Kinase for the treatment for rheumatoid arthritis (RA). The efficacy and safety of tofacitinib in monotherapy or in combination with other DMARDs has been demonstrated...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have